Time to treatment intensification with GLP-1 receptor agonists for patients with type 2 diabetes in the UK: medical record review study

被引：0

作者：

Norrbacka, K. ^{[1
]}

Stein, D. ^{[2
]}

Matza, L. S. ^{[3
]}

Jordan, J. B. ^{[3
]}

Garcia-Perez, L. -E. ^{[4
]}

Hassan, S. W. ^{[4
]}

Boye, K. S. ^{[4
]}

机构：

[1] Eli Lilly Finland, Helsinki, Finland

[2] Evidera, London, England

[3] Evidera, Bethesda, MD USA

[4] Eli Lilly & Co, Indianapolis, IN 46285 USA

来源：

DIABETOLOGIA | 2018年 / 61卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

746

引用

页码：S363 / S364

页数：2

共 50 条

[1] The safety and tolerability of GLP-1 receptor agonists in the treatment of type 2 diabetes: a review
Aroda, Vanita R.
Ratner, Robert
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2011, 27 (06) : 528 - 542
[2] Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a review
Ostergaard, L.
Frandsen, Christian S.
Madsbad, S.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (02) : 241 - 265
[3] GLP-1 receptor agonists for type 2 diabetes
De Block, Christophe E. M.
Van Gaal, Luc F.
LANCET, 2009, 374 (9683): : 4 - 6
[4] Treatment of Type 2 Diabetes With GLP-1 Receptor Agonists Among Patients With CKD
Ostergaard, Jakob A.
Cooper, Mark E.
KIDNEY INTERNATIONAL REPORTS, 2022, 7 (11): : 2323 - 2324
[5] Use of GLP-1 receptor agonists for type 2 diabetes treatment intensification after basal insulin failure
Joubert, M.
Reznik, Y.
DIABETES & METABOLISM, 2017, 43 : 2S34 - 2S38
[6] EVALUATING THE COST-EFFECTIVENESS OF GLP-1 RECEPTOR AGONISTS FOR THE TREATMENT OF TYPE 2 DIABETES IN THE UK
Ashley, D.
Vega, G.
Hunt, B.
Valentine, W. J.
VALUE IN HEALTH, 2015, 18 (07) : A606 - A606
[7] Basal insulin intensification in type 2 diabetes: a key role for GLP-1 receptor agonists
Charbonnel, Bernard
DIABETES & METABOLISM, 2015, 41 : S1 - S2
[8] Systematic review of the efficacy and safety of GLP-1 receptor agonists in the treatment of patients with type 2 diabetes mellitus
Petrova, Lora
Andreevska, Kalina
Parvova, Iva
Petkova, Valentina
PHARMACIA, 2024, 71
[9] GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
Juris J. Meier
Nature Reviews Endocrinology, 2012, 8 : 728 - 742
[10] GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
Meier, Juris J.
NATURE REVIEWS ENDOCRINOLOGY, 2012, 8 (12) : 728 - 742

← 1 2 3 4 5 →